Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: Pragmatic randomized open-label comparison

Human Psychopharmacology

Volumn 22, Issue 7, 2007, Pages 477-482

  Matreja, Prithpal S ^a   Badyal, Dinesh K ^a   Khosla, Prem ^a   Deswal, Randhir S ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Citalopram; Depression; Sertraline

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CITALOPRAM; SERTRALINE;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECG ABNORMALITY; FEMALE; HAMILTON SCALE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SEXUAL DYSFUNCTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADULT; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 35348961423     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.864     Document Type: Article

References (19)

1. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorder, 4th edn, Text Revision. American Psychiatfic Association: Washington D.C.; 356.
2. Baldessarini RJ. 2001. Depression and anxiety disorder. In The Pharmacological Basis of Therapeutics, 10th edn, Hardman JG, Limbird LE (eds). McGraw-Hill: New York; 447-484.
3. Ekselius L, von Knorring L, Eberhard G. 1997. A double blind multicentre trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychophamacol 12: 323-331.
4. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
5. Keene MS, Eaddy MT, Mauch RP, Regan TS, Shah M, Chicio E. 2005. Differences in compliance pattern across the selective serotonin reuptake inhibitors (SSRIs). Curr Med Res Opinin 21: 1651-1658.
6. Micheal JD, Yili L, David JG, John RH, Mark AD. 2002. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double blind, placebo, controlled trial. J Clin Psychiatry 63: 308-315.
7. Montgomery SA, Asberg MC. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
8. Muijser RB, Plosker GL, Noble S. 2002. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs Aging 19: 377-392.
9. Mullin CD, Shaya FT, Meng F, Way J, Harison D. 2005. Persistence, switching and discontinuation rates among patients receiving sertraline, paroxetine and citalopram. Pharmacotherapy 25: 660-667.
10. Nierenberg AA. 2001. Do some antidepressants work faster then others? J Clin Psychiatry 62 (suppl 15): 22-25.
11. Pubmed. 2007 http://www.ncbi.nlm.nih.gov/entrez accessed on 28th may.
12. Rocca P, Calvarese P, Faggiano F, et al. 2005. Citalopram versus sertraline in late life non major clinically significant depression a 1 year follow up clinical trail. J Clin Psychiatry 66: 360-365.
13. Simon GE, Khandker RK, Ichikawa L, Operskalski BH. 2006. Recovery from depression predicts lower health services costs. J Clin Psychiatry 67: 1226-1231.
14. Singh G. 1974. A new depressive inventory (Amritsar Depressive Inventory). Indian J Psychiatry 16: 183-188.
15. Sullivan PW, Valuck R, Sasean J, Macfall HM. 2004. A comparison of direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactors. CNS Drugs 18: 911-932.
16. Thase ME. Methodology to measure onset of action. J Clin Psychiatry 2001. 62 (suppl 15): 18-21.
17. WHO. 2002. The World Health Report 2002-reducing risk, promoting healthy life. World Health Organization: Geneva.
18. Tucker P, Potter-Kimball R, Wyatt DB, et al. 2003. Can physiologic assessment and side effects tease out Differences in PTSD trails? A double blind comparison of citalopram, sertraline and placebo. Psychopharmacol Bull 37: 135-149.
19. Vinar O, Svestka J, Konikova M. 1993. Citalopram in depression. Cesk Psychiar 89: 340-348.